DBS Gets Licence to Underwrite Non-Financial Corporate Bonds in China
By P.R. Venkat
DBS Group has received regulatory approval to underwrite debt financing instruments for non-financial companies in the China Interbank Bond market, making it the first Southeast Asian-headquartered bank to receive the licence.
The approval from China's National Association of Financial Market Institutional Investors will let non-financial enterprises outside China tap DBS's expertise to raise funds from the world's second-largest bond market, the Singapore-based bank said Wednesday.
Last year, DBS was the joint lead underwriter for 3.1 billion Singapore dollars (US$2.3 billion) worth of Panda bonds issued in the China Interbank Bond market, accounting for over 10% of S$26.2 billion Panda bonds issued in 2023.
Panda bonds are a common term for yuan-denominated debt issued in China's onshore market by non-Chinese companies, governments, and organizations.
"DBS has supported several multilateral development banks, foreign governments, and European financial institutions to issue Panda bonds, some of which were inaugural issuances," said the bank's global head of fixed income, Clifford Lee.
Write to P.R. Venkat at venkat.pr@wsj.com
(END) Dow Jones Newswires
February 13, 2024 23:31 ET (04:31 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track